Where is the biopharma outsourcing market truly heading? Eric Langer, BioPlan Associates, Inc. to present at PBOA 10th Annual Meeting & Conference on October 22–23, 2026, at the Bethesda North Marriott in Rockville, MD - https://t.co/miNVKeu1gk #cdmo
BioPharma generally agrees about the advantages of perfusion cell-culture technologies, but adoption remains lower than expected - "Continuous Biomanufacturing and Perfusion Technologies Are Finally on the Cusp of Broad Adoption" - https://t.co/ZgoUb3MEVx @BioPlanInc 23rd Annual
🎧 Episode 2/The BWS Dialogues™ is Available! 🎧 Listen Now: https://t.co/kBeCFcWkjo
@BioPlanInc shares insights with Brandwidth Solutions about challenges CDMOs face today, including the role of geopolitics, changes to H-1B visa rules! #CDMOs#Employment#BioPharma#h1bvisas
Find the right CDMO facilities for your projects and optimize your research with @BioPlanInc's Comprehensive CDMO Biologics Manufacturers in Global Facilities Database. - https://t.co/2srSA9N7XZ #CDMO#Biotech#Bioprocessing#Biomanufacturing
NEW! BioPharma By the Numbers infographic series from @BioPharmIntl - data-driven look at @BioPlanInc's 22nd Annual Report featuring key sectors, trends, and topics in the biopharma industry. First up - Rise in Bioprocessing Automation!
https://t.co/O9DkRy8CLh
@BioPlanInc Top1000Bio Global Bioprocessing Facilities Database - Comprehensive Profiles of Biologics Manufacturers https://t.co/A0Wcq5Nme0
Find new BioFacilities; 20 years of data; mAbs, microbial, single-use, cell/gene therapy, CDMOs by capacity and type #MarketIntelligence
Nearly 40% Of #Biomanufacturers Eyeing Continuous Processing - @BioProcessOL, https://t.co/cAFG49hvlv
According to @BioPlanInc 22nd Annual Report and Survey of Biopharmaceutical Manufacturing.
Is the Biopharma Outsourcing Market "Fractured" or Just Flexible? - https://t.co/aZJMhEshvD.
Great editorial posted by @Louis_Garguilo@OutsourcedPharm highlighting @BioPlanInc 22nd Annual Report/Survey, and suggests what some see as fractures are signs of a flexible market.
Eric Langer, @BioPlanInc and Larry West, Aspen Media, will present "Economic Outlook and Trends for the Single-Use Industry" at @BPSAsocma Summit #BPSASummit25 on July 22! REGISTER TODAY! https://t.co/C3gBB03I1D Reach out if you would want to connect! #singleuse#bioprocessing
It's here! @BioPlanInc 22nd Annual Report and Survey of #Biopharmaceutical Capacity and Production - https://t.co/qV8ucfw3cF
22 years of trend analysis, 200 data-rich graphs and tables, 550+ comprehensive pages! Biopharma's most comprehensive industry overview! #Biomanufacturing
Share your #biopharma expertise! @BioPlanInc is conducting our comprehensive global analysis. All qualified surveys will receive an Amazon e-gift card, summary results, and our 2025 Top Trends in Biomanufacturing White Paper! Click here to start - https://t.co/n0ylzCz38D
@BioPlanInc Latest Bioprocess Trends and Insights in 21st Annual Report Available Now. Your must-have industry data resource for biomanufacturing! https://t.co/cYMKX3eHfh
Join @BioPlanInc at the 2024 @ContractPharma Annual Contracting and Outsourcing Conference, Sept 26-27, 2024, Hyatt Regency, New Brunswick, NJ, as we talk about "Critical Trends & Growth in Biopharma Contract Manufacturing" - https://t.co/Hdr6DB4mGj #biopharma#biotech
Wish #SUS Cost Less? Survey Says Your Peers Do, Too https://t.co/yIxgnRjlgo, @BioProcessOL - By Ioanna Deni, Contributing Author. @BioPlanInc 21st Annual Report shows low-cost SUS is single most important new product development area suppliers need to focus efforts on in 2024.
#SingleUse Suppliers to #Bioprocessing project 13.5% growth in 2024 based on recent @BioPlanInc survey at @BPSAsocma Summit July 2024 in Washington DC. Additional insights? Check out @BioPlanInc - https://t.co/ly708hfHoC. Smart science. Data-driven results. Trusted expertise.